MISSION
The objective of the UC-Denver Microbiome Research Consortium (MiRC) is to facilitate collaborative, innovative studies of the human-microbe interface (the "microbiome" at the University of Colorado and at-large. MiRC provides the expertise and infrastructure required for all facets of microbiome research. From bedside to bench to bioinformatics. Our projects have explored the roles played by human-associated microbes in diverse human conditions including:
- Cystic Fibrosis
- Bronchopulmonary Dysplasia
- Ventilator Associated Pneumonia
- Chronic Obstructive Pulmonary Disease
- Asthma
- Children's Interstitial Lung Diseases
- Eosinophilic Esophagitis
- Inflammatory Bowel Disease
- Mother-to-child transmission of HIV-1
- Chronic Wounds
- Staphylococcus areus colonization
- Type 1 Diabetes
- Micronutrient excess
- Short bowel syndrome
- Catheter biofilms
- Impact of vaccination
These studies have been carried out in the U.S. and in resource-limited countries.
MiRC PERSONNEL
Please contact us if you have a specific microbiome-related project in mind or want more general information.
Daniel N. Frank, Ph.D. (Co-director)
Gastrointestinal and skin/nasal microbiota
Assistant Professor
University of Colorado - School of Medicine
Division of Infectious Diseases
Mucosal and Vaccine Research Colorado (MAVRC)
Microbiome Research Consortium Colorado (MiRC)
Anschutz Medical Center
12700 E. 19th Avenue, RC2 - Room 11007
Aurora, CO 80045
303-724-5536
daniel.frank@ucdenver.edu
J. Kirk Harris, PhD. (Co-director)
Respiratory microbiota and model system microbiota
Assistant Professor
University of Colorado - School of Medicine
Department of Pediatrics, Pulmonary Medicine
Mucosal and Vaccine Research Colorado (MAVRC)
Microbiome Research Colorado (MiRC)
Children's Hospital
13123 E. 16th Avenue, B396
Aurora, CO 80045
720-777-4943
jonathan.harris@ucdenver.edu